Log in to save to my catalogue

ZNF 671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

ZNF 671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2266316950

ZNF 671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

About this item

Full title

ZNF 671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

Publisher

Tokyo: John Wiley & Sons, Inc

Journal title

Cancer science, 2019-03, Vol.110 (3), p.1105-1116

Language

English

Formats

Publication information

Publisher

Tokyo: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Serous ovarian cancer is the most frequent type of epithelial ovarian cancer. Despite the use of surgery and platinum‐based chemotherapy, many patients suffer from recurrence within 6 months, termed platinum resistance. Currently, the lack of relevant molecular biomarkers for the prediction of the early recurrence of serous ovarian cancers is linke...

Alternative Titles

Full title

ZNF 671 DNA methylation as a molecular predictor for the early recurrence of serous ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2266316950

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2266316950

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.13936

How to access this item